Skip to main content

Table 2 Choroidal thickness adjusted for age, sex, baseline axial length and refractive error in different regions

From: Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 3-year follow-up study

Time

Group

SF

C

N3

T3

S3

I3

N6

T6

S6

I6

Baseline

HAL (μm)

236.83 ± 58.03

238.59 ± 57.16

213.64 ± 54.55

252.58 ± 56.47

249.32 ± 55.3

240.37 ± 55.97

170.91 ± 49.18

259.47 ± 52.82

253.47 ± 54.22

234.03 ± 52.58

SAL-HAL (μm)

227.8 ± 57.71

230.72 ± 56.84

209.6 ± 54.24

245.33 ± 56.15

241.66 ± 54.98

238.96 ± 55.66

171.23 ± 48.9

255.65 ± 52.52

247.32 ± 53.92

241.26 ± 52.28

SVL-HAL (μm)

215.96 ± 57.4

217.1 ± 56.54

195.81 ± 53.97

231.47 ± 55.86

225.12 ± 54.7

225.18 ± 55.37

159.04 ± 48.65

237.81 ± 52.25

230.83 ± 53.65

219.97 ± 52.01

new-SVL (μm)

234.2 ± 58.04

233.22 ± 57.17

205.69 ± 54.56

250.6 ± 56.48

242.3 ± 55.31

237.17 ± 55.99

161.49 ± 49.19

258.4 ± 52.83

242.84 ± 54.23

227.4 ± 52.59

6 months

HAL (μm)

232.45 ± 62.94

240.65 ± 59.02

215.55 ± 56.84

255.14 ± 57.97

251.62 ± 57.66

242.76 ± 58.93

171.18 ± 51.8

261.9 ± 53.92

255.66 ± 56.88

234.88 ± 56.2

SAL-HAL (μm)

221.96 ± 62.59

234.06 ± 58.69

212.45 ± 56.52

248.33 ± 57.65

246.35 ± 57.33

243.41 ± 58.61

171.49 ± 51.51

259.11 ± 53.62

250.65 ± 56.56

243.83 ± 55.88

SVL-HAL (μm)

216.16 ± 62.26

222.3 ± 58.38

200.29 ± 56.23

237.49 ± 57.35

231.52 ± 57.04

230.55 ± 58.3

159.09 ± 51.24

247.63 ± 53.34

236.78 ± 56.27

225.49 ± 55.6

new-SVL (μm)

222.4 ± 62.95

226.23 ± 59.04

199.77 ± 56.85

241.65 ± 57.98

237.24 ± 57.67

230.51 ± 58.95

156.14 ± 51.8

250.96 ± 53.93

240.03 ± 56.89

221.95 ± 56.21

12 months

HAL (μm)

231.74 ± 58.69

234.66 ± 58.51

211.85 ± 56.17

247.27 ± 56.37

245.97 ± 56.62

237.13 ± 58.22

170.71 ± 51.6

253.14 ± 51.65

251.22 ± 56.24

231.76 ± 55.41

SAL-HAL (μm)

225.58 ± 58.36

229.19 ± 58.18

208.11 ± 55.86

241.98 ± 56.06

242.73 ± 56.3

240.05 ± 57.89

171.18 ± 51.31

252.42 ± 51.36

249.02 ± 55.93

242.57 ± 55.1

SVL-HAL (μm)

215.84 ± 58.05

216.72 ± 57.88

195.5 ± 55.57

230.36 ± 55.77

226.68 ± 56

225.22 ± 57.59

157.91 ± 51.05

237.37 ± 51.09

234.01 ± 55.64

220.38 ± 54.81

new-SVL (μm)

218.1 ± 58.7

217.11 ± 58.52

193.87 ± 56.18

232.22 ± 56.39

228.73 ± 56.62

222.88 ± 58.22

154.05 ± 51.62

240.44 ± 51.66

234.8 ± 56.25

215.77 ± 55.42

RM-MANOVA, P value

Time

0.661

0.372

0.525

0.551

0.515

0.431

0.942

0.396

0.468

0.937

Group

0.550

0.433

0.429

0.465

0.305

0.573

0.378

0.414

0.321

0.192

Time × group

0.100

0.006

0.025

0.001

0.005

0.003

0.175

< 0.001

0.086

0.009

RM-MANOVA in each group, P value

HAL

0.434

0.116

0.311

0.037

0.115

0.112

0.892

0.014

0.174

0.375

SAL-HAL

0.384

0.173

0.187

0.066

0.210

0.211

0.964

0.051

0.455

0.583

SVL-HAL

0.983

0.173

0.166

0.094

0.107

0.147

0.926

0.003

0.119

0.095

new-SVL

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

0.001

< 0.001

0.005

< 0.001

  1. HAL group, continued wearing HAL; SAL-HAL group, switched from wearing SAL to HAL; SVL-HAL group, switched from wearing SVL to HAL; new-SVL group, wore SVL for 1 year
  2. P < 0.005 indicates statistical significance
  3. HAL = spectacle lenses with highly aspherical lenslets; SAL = spectacle lenses with slightly aspherical lenslets; SVL = single vision spectacle lenses; SF = subfoveal choroidal thickness; C = 1 × 1 mm circular region; N3, S3, T3 and I3 = the nasal, superior, temporal and inferior regions measured at 1–3 mm; N6, S6, T6 and I6 = the nasal, superior, temporal and inferior regions measured at 3–6 mm; RM-MANOVA = repeated-measures multivariate analysis of variance